(Q40883862)

24 September 2017

title

Amifostine cytotoxicity and induction of apoptosis in a human myelodysplastic cell line (English)

1 reference

24 September 2017

0 references

0 references

Ribizzi I

1

1 reference

24 September 2017

Darnowski JW

2

1 reference

24 September 2017

Goulette FA

3

1 reference

24 September 2017

Sertoli MR

4

1 reference

24 September 2017

Calabresi P

5

1 reference

24 September 2017

publication date

1 June 2000

1 reference

24 September 2017

1 reference

24 September 2017

volume

24

1 reference

24 September 2017

issue

6

1 reference

24 September 2017

page(s)

519-525

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900007-2

24 September 2017

1 reference

7 January 2021

The myelodysplastic syndromes: biology and implications for management

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900007-2

7 January 2021

The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900007-2

7 January 2021

Treatment of advanced myelodysplastic syndrome with alfacalcidol

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900007-2

7 January 2021

The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900007-2

7 January 2021

WR-2721 protects against the hematologic toxicity of cyclophosphamide: a controlled phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900007-2

7 January 2021

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900007-2

7 January 2021

Amifostine stimulates formation of multipotent and erythroid bone marrow progenitors

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900007-2

7 January 2021

Effects of the modulating agent WR2721 on myelotoxicity and antitumour activity in carboplatin-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900007-2

7 January 2021

10.1016/S0145-2126(00)00007-2

Identifiers

DOI

1 reference

24 September 2017

1 reference